Research paper| Volume 19, ISSUE 1, P103-117, January 1974

The effect of d-thyroxine on the metabolism of cholesterol in familial hyperbetalipoproteinaemia

      This paper is only available as a PDF. To read, Please Download here.


      The effect of d-thyroxine plus propranolol on cholesterol metabolism was investigated in three patients with familial hyperbetalipoproteinaemia whose plasma cholesterol was labelled with [14C]cholesterol. In each patient the treatment caused a fall in plasma cholesterol concentration and a temporary increase in faecal excretion of endogenous steroids, due to increased output of neutral steroids in two patients and to increased output of bile acids in the third patient. The cumulative increase in output of endogenous steroids during treatment was greater than the amount of cholesterol lost from the plasma. Since the specific radioactivity curve of the plasma cholesterol did not indicate increased synthesis of cholesterol during the treatment, it was concluded that cholesterol mobilized from the tissues, as well as plasma cholesterol, contributed to the increase in faecal excretion of endogenous steroids.


      To read this article in full you will need to make a payment

      Purchase one-time access:

      Academic & Personal: 24 hour online accessCorporate R&D Professionals: 24 hour online access
      One-time access price info
      • For academic or personal research use, select 'Academic and Personal'
      • For corporate R&D use, select 'Corporate R&D Professionals'


      Subscribe to Atherosclerosis
      Already a print subscriber? Claim online access
      Already an online subscriber? Sign in
      Institutional Access: Sign in to ScienceDirect


        • Strisower B.
        • Gofman J.W.
        • Rubin L.
        • Rosenthal D.
        • De Lalla O.
        The effect of desiccated thyroid on the hyperlipoproteinemia of xanthoma tendinosum.
        Amer. J. Med. Sci. 1960; 239: 71
        • Boyd G.S.
        • Oliver M.F.
        Thyroid hormones and plasma lipids.
        Brit. Med. Bull. 1960; 16: 138
        • Myant N.B.
        The thyroid and lipid metabolism.
        in: Paoletti R. Lipid Pharmacology. Academic Press, New York, N.Y1964: 299
        • Myant N.B.
        • Slack J.
        Type II hyperlipoproteinaemia.
        Clin. Endocrinol. Metab. 1973; 2: 81
        • Coronary drug project
        Findings leading to further modifications of its protocol with respect to dextrothyroxine.
        J. Amer. Med. Ass. 1972; 220: 996
        • Krikler D.M.
        • Lefevre D.
        • Lewis B.
        Dextrothyroxine with propranolol in treatment of hypercholesterolaemia.
        Lancet. 1971; i: 934
        • Beaumont J.-L.
        • Carlson L.A.
        • Cooper G.R.
        • Fejfar Z.
        • Fredrickson D.S.
        • Strasser T.
        Classification of hyperlipidaemias and hyperlipoproteinaemias.
        Bull. W.H.O. 1970; 43: 891
        • Lewts B.
        • Myant N.B.
        Studies in the metabolism of cholesterol in subjects with normal plasma cholesterol levels and in patients with essential hypercholesterolaemia.
        Clin. Sci. 1967; 32: 201
        • Whitby L.G.
        • Lang D.
        Experience with the chromic oxide method of fecal marking in metabolic balance investigations of humans.
        J. Clin. Invest. 1960; 39: 854
        • Grundy S.M.
        • Ahrens Jr, E.H.
        • Salen G.
        Dietary β-sitosterol as an internal standard to correct for cholesterol losses in sterol balance studies.
        J. Lipid Res. 1968; 9: 374
        • Borgström B.
        Quantification of cholesterol absorption in man by fecal analysis after feeding of a single isotope-labeled meal.
        J. Lipid Res. 1969; 10: 331
        • Clark B.R.
        • Rubin R.T.
        • Arthur R.J.
        A new micro-method for determination of cholesterol in serum.
        Anal. Biochem. 1968; 24: 27
        • Folch J.
        • Lees M.
        • Sloane Stanley G.H.
        A simple method for the isolation and purification of total lipides from animal tissues.
        J. Biol. Chem. 1957; 226: 497
        • Fisher M.T.
        • Atkins P.R.
        • Joplin G.F.
        A method for measuring faecal chromium and its use as a marker in human metabolic balances.
        Clin. Chim. Acta. 1972; 41: 109
        • Grundy S.M.
        • Ahrens Jr, E.H.
        • Miettinen T.A.
        Quantitative isolation and gas-liquid chromatographic analysis of total fecal bile acids.
        J. Lipid Res. 1965; 6: 397
        • Hellman L.
        • Rosenfeld R.S.
        • Insull Jr, W.
        • Ahrens Jr, E.H.
        Intestinal excretion of cholesterol: a mechanism for regulation of plasma levels.
        J. Clin. Invest. 1957; 36: 898
        • Moutafis C.D.
        • Myant N.B.
        The metabolism of cholesterol in two hypercholesterolaemic patients treated with cholestyramine.
        Clin. Sci. 1969; 37: 443
        • Miettinen T.A.
        Mechanism of serum cholesterol reduction by thyroid hormones in hypothyroidism.
        J. Lab. Clin. Med. 1968; 71: 537